BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 28767714)

  • 1. HIV-associated mortality in the era of antiretroviral therapy scale-up - Nairobi, Kenya, 2015.
    Young PW; Kim AA; Wamicwe J; Nyagah L; Kiama C; Stover J; Oduor J; Rogena EA; Walong E; Zielinski-Gutierrez E; Imbwaga A; Sirengo M; Kellogg TA; De Cock KM
    PLoS One; 2017; 12(8):e0181837. PubMed ID: 28767714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of an HIV-Related Mortuary Surveillance System - Nairobi, Kenya, Two Sites, 2015.
    Ali H; Kiama C; Muthoni L; Waruru A; Young PW; Zielinski-Gutierrez E; Waruiru W; Harklerode R; Kim AA; Swaminathan M; De Cock KM; Wamicwe J
    MMWR Surveill Summ; 2018 Dec; 67(14):1-12. PubMed ID: 30574955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High HIV prevalence among decedents received by two high-volume mortuaries in Kisumu, western Kenya, 2019.
    Onyango DO; van der Sande MAB; Musingila P; Kinywa E; Opollo V; Oyaro B; Nyakeriga E; Waruru A; Waruiru W; Mwangome M; Macharia T; Young PW; Junghae M; Ngugi C; De Cock KM; Rutherford GW
    PLoS One; 2021; 16(7):e0253516. PubMed ID: 34197509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-Related Deaths in Nairobi, Kenya: Results From a HIV Mortuary Surveillance Study, 2015.
    Nyagah LM; Young PW; Kim AA; Wamicwe J; Kimani M; Waruiru W; Rogena E; Oduor J; Walong E; Waruru A; Oyugi J; Downer M; De Cock KM; Sirengo M
    J Acquir Immune Defic Syndr; 2019 May; 81(1):18-23. PubMed ID: 30964803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV mortality in urban slums of Nairobi, Kenya 2003-2010: a period effect analysis.
    Oti SO; Mutua M; Mgomella GS; Egondi T; Ezeh A; Kyobutungi C
    BMC Public Health; 2013 Jun; 13():588. PubMed ID: 23773503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. InterVA versus Spectrum: how comparable are they in estimating AIDS mortality patterns in Nairobi's informal settlements?
    Oti SO; Wamukoya M; Mahy M; Kyobutungi C
    Glob Health Action; 2013 Oct; 6():21638. PubMed ID: 24160914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of advanced HIV disease from three high HIV prevalence settings in Sub-Saharan Africa: a secondary analysis data from three population-based cross-sectional surveys in Eshowe (South Africa), Ndhiwa (Kenya) and Chiradzulu (Malawi).
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Goemaere E; Wanjala S; Masiku C; Szumilin E; Etard JF; Maman D; Davies MA
    Glob Health Action; 2019; 12(1):1679472. PubMed ID: 31679482
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of non-communicable diseases among key populations enrolled at a large HIV prevention & treatment program in Kenya.
    Achwoka D; Oyugi JO; Mutave R; Munywoki P; Achia T; Akolo M; Muriuki F; Muthui M; Kimani J
    PLoS One; 2020; 15(7):e0235606. PubMed ID: 32614906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya.
    van't Hoog AH; Williamson J; Sewe M; Mboya P; Odeny LO; Agaya JA; Amolloh M; Borgdorff MW; Laserson KF
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1649-56. PubMed ID: 23131264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.
    Jahn A; Floyd S; Crampin AC; Mwaungulu F; Mvula H; Munthali F; McGrath N; Mwafilaso J; Mwinuka V; Mangongo B; Fine PE; Zaba B; Glynn JR
    Lancet; 2008 May; 371(9624):1603-11. PubMed ID: 18468544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya.
    Onyango DO; Yuen CM; Cain KP; Ngari F; Masini EO; Borgdorff MW
    PLoS One; 2017; 12(11):e0188235. PubMed ID: 29145454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.
    Blair JM; Fagan JL; Frazier EL; Do A; Bradley H; Valverde EE; McNaghten A; Beer L; Zhang S; Huang P; Mattson CL; Freedman MS; Johnson CH; Sanders CC; Spruit-McGoff KE; Heffelfinger JD; Skarbinski J;
    MMWR Suppl; 2014 Jun; 63(5):1-22. PubMed ID: 24941443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of completeness, correctness, and order of cause of death statements among decedents with documented causes of death and HIV status at two major mortuaries in Kenya, 2015.
    Rogena EA; Waruru A; Young PW; Abade P; Nyagah LM; Walong EO
    J Forensic Leg Med; 2020 Jul; 73():101993. PubMed ID: 32658751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Causes of Adult Deaths among the Urban Poor: Evidence from Nairobi Urban Health and Demographic Surveillance System, 2003-2012.
    Mberu B; Wamukoya M; Oti S; Kyobutungi C
    J Urban Health; 2015 Jun; 92(3):422-45. PubMed ID: 25758599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of mortality within the first year of initiating antiretroviral therapy in urban and rural Kenya: A prospective cohort study.
    Silverman RA; John-Stewart GC; Beck IA; Milne R; Kiptinness C; McGrath CJ; Richardson BA; Chohan B; Sakr SR; Frenkel LM; Chung MH
    PLoS One; 2019; 14(10):e0223411. PubMed ID: 31584992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some effects of the rising case load of adult HIV-related disease on a hospital in Nairobi.
    Gilks CF; Floyd K; Otieno LS; Adam AM; Bhatt SM; Warrell DA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jul; 18(3):234-40. PubMed ID: 9665500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of "test and treat" recommendations on eligibility for antiretroviral treatment: Cross sectional population survey data from three high HIV prevalence countries.
    Chihana ML; Huerga H; Van Cutsem G; Ellman T; Wanjala S; Masiku C; Szumilin E; Etard JF; Davies MA; Maman D
    PLoS One; 2018; 13(11):e0207656. PubMed ID: 30475865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Risk Factors for Recent HIV Infection in Kenya Using a Recent Infection Testing Algorithm: Results from a Nationally Representative Population-Based Survey.
    Kim AA; Parekh BS; Umuro M; Galgalo T; Bunnell R; Makokha E; Dobbs T; Murithi P; Muraguri N; De Cock KM; Mermin J;
    PLoS One; 2016; 11(5):e0155498. PubMed ID: 27195800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased HIV-associated mortality rates during scale-up of antiretroviral therapy, 2011-2016.
    Otieno G; Whiteside YO; Achia T; Kwaro D; Zielinski-Gutierrez E; Ojoo S; Sewe M; Musingila P; Akelo V; Obor D; Nyaguara A; De Cock KM; Borgdorff MW
    AIDS; 2019 Dec; 33(15):2423-2430. PubMed ID: 31764107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV incidence in western Kenya during scale-up of antiretroviral therapy and voluntary medical male circumcision: a population-based cohort analysis.
    Borgdorff MW; Kwaro D; Obor D; Otieno G; Kamire V; Odongo F; Owuor P; Muthusi J; Mills LA; Joseph R; Schmitz ME; Young PW; Zielinski-Gutierrez E; De Cock KM
    Lancet HIV; 2018 May; 5(5):e241-e249. PubMed ID: 29650451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.